Skip to main content
Premium Trial:

Request an Annual Quote

Roche Merges Japanese Subsidiary with Chugai

NEW YORK, Dec. 10 – Swiss pharmaceutical company Roche said Monday it was merging its Nippon Roche subsidiary with Japanese pharmaceutical company Chugai in a new entity that will be named Chugai Pharmaceutical. 

Chugai chairman and CEO, Osamu Nagayama, will be the chairman and CEO of the merged company. Wataru Ogawa, Nippon Roche’s current president and CEO, will be nominated for a seat on the board of directors. Roche will hold 50.1 percent of the company’s shares.

The new company will be managed autonomously, but the companies said that Chugai’s activities would be coordinated with Roche.

"The combination of Chugai's and Nippon Roche's skilled employees together with the current product portfolio and pipelines, which are complementary and particularly focused on the growth segments of the Japanese markets, will enable us to create a very solid franchise in the Japanese market over the coming years,” Nagayama said in a statement.

 “Through this alliance Chugai becomes the first Japanese pharmaceutical company to have access to all world markets." 

Chugai will be Roche's exclusive pharmaceutical representative in Japan and will have rights to develop and market pharmaceutical products Roche decides to commercialize in Japan. Roche will have the right to license all Chugai products outside of Japan and South Korea for which Chugai seeks a partner.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.